Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis secures approval in China for Cosentyx
This approval in China follows the recent approval of Cosentyx in the United States and Europe for the treatment of…
EMA validates Bristol Myers Squibb’s two Opdivo-based applications to treat cell carcinoma
The applications are based on positive results from the phase-III CheckMate-648 trial, in which both Opdivo-based combinations…
GSK receives US FDA approval for Jemperli to treat advanced solid tumours
GARNET study demonstrated an objective response rate of 41.6 per cent across dMMR solid tumours
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early…
The formal conclusions from the trial appear in the current online issue of The New England Journal of Medicine
Industry Knowledge eXchange: Redefining Job Roles – Employee Enablement for Digital Adoption in…
18th August 2021 | 3:30 PM - 5:00 PM IST | Live Event
Second-generation mRNA COVID-19 vaccine candidate, CV2CoV, demonstrates improved immune response and…
Pre-clinical study provides evidence for improved immune responses with second-generation mRNA backbone jointly developed by…
Next Generation Cell Factories: From Designer Cells to Optimized Processes | 25th August 2021
25th August 2021 | 3:00 PM - 4:15 PM IST | Live Webinar
Covishield’s booster dose desirable, says Cyrus Poonawalla
Since there was a shortage of the vaccine, the Modi government changed it to three months, but a two-month gap is ideal,"…
Bharat Biotech’s intra-nasal COVID vaccine gets DCGI nod for phase-II and -III trials
Phase-I clinical trial has been completed in age groups ranging from 18 to 60 years
Wellness Forever opens 15 new stores across three states
The pharmacies will consist of a wide range of products of prescribed medicines, over-the-counter drugs, wellness and nutrition…